MedTrace Logo

Prostaglandins Before Caserean Section

NCT03366259 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2017-12-11

No results posted yet for this study

Summary

The aim of our study is to assess the value of administration of prostaglandins before cesarean section to reduce the amount of blood loss

Conditions

  • Intrapartum Hemorrhage

Interventions

DRUG

Misoprostol 200Mcg Tab

administration of 200 Mcg of misoprotol rectal

PROCEDURE

elective cesarean section

elective cesarean section for full term patients

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366259 on ClinicalTrials.gov